Fig. 3From: Controlled evaLuation of Angiotensin Receptor Blockers for COVID-19 respIraTorY disease (CLARITY): statistical analysis plan for a randomised controlled Bayesian adaptive sample size trialEstimated probability of the trial stopping for a effectiveness, b futility and c average sample sizes based on a variety of different assumptions about the odds ratio, recruitment rate and data that will be observedBack to article page